Long-term recovery from unawareness, deficient counterregulation and lack of cognitive dysfunction during hypoglycaemia, following institution of rational, intensive insulin therapy in IDDM

Diabetologia

Volumn 37, Issue 12, 1994, Pages 1265-1276

  Fanelli, C ^a   Pampanelli, S ^a   Epifano, L ^a   Rambotti, A M ^a   Di Vincenzo, A ^a   Modarelli, F ^a   Ciofetta, M ^a   Lepore, M ^a   Annibale, B ^b   Torlone, E ^a   Perriello, G ^a   De Feo, P ^a   Santeusanio, F ^a   Brunetti, P ^a   Bolli, G B ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Autonomic neuropathy; catecholamines; glucose counterregulation; hypoglycaemia unawareness; intensive insulin therapy

Indexed keywords

ADRENALIN; GLUCAGON; INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRIORITY JOURNAL;

ADULT; AWARENESS; BLOOD GLUCOSE; BODY MASS INDEX; COGNITION; DIABETES MELLITUS, TYPE 1; EPINEPHRINE; FEMALE; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYDROCORTISONE; HYPOGLYCEMIA; INSULIN; MALE; NOREPINEPHRINE; PANCREATIC POLYPEPTIDE; REFERENCE VALUES; TIME FACTORS;

EID: 0028072770     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/BF00399801     Document Type: Article

References (53)

1. Hypoglycemia unawareness
2. Unawareness of hypoglycemia in insulin-treated diabetic patients: prevalence and relationship to autonomic neuropathy
3. Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia
4. Identification of type 1 diabetic patients at increased risk for hypoglycemia during intensive therapy
5. A reliable and reproducible test for adequate glucose counterregulation in type 1 diabetes mellitus
6. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
8. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus
9. Blood glucose concentrations and progression of diabetic retinopathy: the seven year results of the Oslo study
10. Influence of sympathetic nervous system on hypoglycemic warning symptoms
11. Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release
12. Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM. A vicious circle
13. Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans
14. Counterregulatory adaptation to recurrent hypoglycemia in normal humans
15. Induction of hypoglycemia unawareness by asymptomatic nocturnal hypoglycemia
16. Intermittent hypoglycemia impairs glucose counterregulation
17. Compromised hormonal counterregulation, symptom awareness, and neurophysiological function after recurrent short-term episodes of insulin-induced hypoglycemia in IDDM patients
18. Evidence for reversibility of defective counterregulation in a patient with insulinoma
19. Reversibility of unawareness of hypoglycemia in patients with insulinomas
20. Restoration of impaired Counterregulatory hormone response, symptom perception and cerebral function by short-term euglycemia in IDDM
21. Improved hormonal and symptomatic responses to hypoglycemia in IDDM patients after three months of less strict glucose control
22. Enhanced epinephrine responses during hypoglycemia in IDDM patients on conventional therapy following intensive insulin therapy
23. Meticulous prevention of hypoglycemia (near-)normalizes magnitude and glycemic thresholds of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with IDDM of short duration
24. Nocturnal blood glucose control in type 1 diabetes mellitus
25. Diagnosis and management of diabetic autonomic neuropathy
26. Hierarchy of glycemic thresholds for Counterregulatory hormone secretion, symptoms, and cerebral dysfunction
27. Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in, hypoglycaemia in humans
28. Effects of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with IDDM
29. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the thresholds for symptoms
30. Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysis
31. Gastric acid and pancreatic polypeptide responses to modified sham feeding: indication of an increased basal vagal tone in a subgroup of duodenal ulcer patients
32. Chronic hypoglycemia increases brain glucose transport
33. Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics
34. Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man
35. Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus
36. Lack of protection of cerebral function in well controlled diabetic patients with hypoglycemia unawareness
37. Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes
38. Multifactorial origin of hypoglycemia unawareness in IDDM: association with defective glucose counterregulation and better glycemic control
39. Physiological disturbances in hypoglycaemia: effect on subjective awareness
40. Effects of insulin after adrenalectomy
41. Metabolic and cardiovascular responses to epinephrine in diabetic autonomic neuropathy
42. Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha-cell defect
43. Abnormal glucose counterregulation in insulin-dependent diabetes mellitus. Interaction of anti-insulin antibodies and impaired glucagon and epinephrine secretion
44. Abnormal glucose counterregulation after subcutaneous insulin in insulin-dependent diabetes mellitus
45. Suppression of counterregulatory hormone response to hypoglycemia by insulin per se
46. A high concentration of insulin suppresses the glucagon response to hypoglycemia in man
47. Inhibitory effect of circulating insulin on glucagon secretion during hypoglycaemia in type I diabetes
48. Epidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
49. Insulin pharmacokinetics